Robie N W
Fed Proc. 1984 Apr;43(5):1371-4.
alpha-Adrenergic agonists have been reported to decrease the release of neuronal norepinephrine (NE) via presynaptic alpha 2 receptors when studied under in vitro conditions. Within the last several years studies have been performed in the intact animal to determine whether this presynaptic mechanism is a pharmacological artifact or whether it plays a functional role in cardiovascular physiology. In the intact renal vascular bed clonidine, oxymetazoline, and NE did not decrease stimulation-induced vasoconstrictor responses relative to constrictor responses produced by exogenous NE. Similarly, the alpha-receptor antagonists yohimbine and phentolamine did not potentiate constrictor responses induced by renal nerve stimulation. Studies involving the heart produce contradictory results. Clonidine and NE have been reported to decrease or have no effect on chronotropic responses to cardiac nerve stimulation. Phenoxybenzamine and desipramine have been reported to increase the overflow of NE in coronary sinus blood during cardiac nerve stimulation but not to potentiate chronotropic responses. Thus, this brief review points out that the functional importance of a presynaptic mechanism to modulate the release of NE still remains to be determined.
据报道,在体外条件下进行研究时,α-肾上腺素能激动剂可通过突触前α2受体减少神经元去甲肾上腺素(NE)的释放。在过去几年中,已在完整动物身上开展研究,以确定这种突触前机制是一种药理学假象,还是在心血管生理学中发挥功能性作用。在完整的肾血管床中,可乐定、羟甲唑啉和去甲肾上腺素相对于外源性去甲肾上腺素产生的收缩反应,并未降低刺激诱导的血管收缩反应。同样,α受体拮抗剂育亨宾和酚妥拉明也未增强肾神经刺激诱导的收缩反应。涉及心脏的研究产生了相互矛盾的结果。据报道,可乐定和去甲肾上腺素可降低或对心脏神经刺激的变时反应无影响。据报道,酚苄明和地昔帕明可增加心脏神经刺激期间冠状窦血中去甲肾上腺素的溢出,但不会增强变时反应。因此,这篇简短的综述指出,调节去甲肾上腺素释放的突触前机制的功能重要性仍有待确定。